Jeanie Herbert | Senior Director of IR & Corporate Communications |
Mark Foley | President & CEO |
Tobin Schilke | CFO & Principal Accounting Officer |
Abhay Joshi | COO |
Dustin Sjuts | Head of Commercial, Aesthetics & Therapeutics |
Annabel Samimy | Stifel |
David Amsellem | Piper Jaffray |
Jacob Hughes | Wells Fargo |
Stacy Ku | Cowen & Company |
Douglas Tsao | H.C. Wainwright |
Tim Lugo | William Blair |
Difei Yang | Mizuho Securities |
Serge Belanger | Needham |
Seamus Fernandez | Guggenheim |
Welcome to the Revance Therapeutics Third Quarter 2019 Financial Results and Corporate Update Conference Call. [Operator Instructions] As a reminder, this call is being recorded today, November 4, 2019.
I would like to turn the conference call over to Jeanie Herbert, Senior Director of Investor Relations and Corporate Communications for Revance. Ma'am, please go ahead.
Thank you, Towanda.